Breast cancer as the most common cancer among women annually causes one million new cases in the world. Chemotherapy is considered to be one of the main treatments for the disease. Zoledronic acid (Zol) is a bisphosphonate agent used in the treatment of osteoporosis. However, many studies have recently shown the anticancer potency of the drug. We here encapsulated Zol in liposome nanoparticles (NPs) and evaluated its efficacy on mouse breast cancer cell line 4T1. The size, size distribution and zeta potential of the drug loaded NPs were 157 nm, 0.285 and -43 mV, respectively. Zol entrapment efficiency was also calculated and was found to be 9%. Cytotoxicity evaluation indicated the superior anticancer activity of nanodrug compare to standard drug by 2.5 folds enhancement. Finally, the results of study suggested in vivo evaluation of formulation.
Introduction
Breast cancer-the most common cancer among women-causes one million new cases diagnosed each year worldwide (Bonilla et al., 2015) . Chemotherapy is one of the main treatments for breast cancer; however it comes with some serious side effects, such as nonspecific cytotoxicity, poor aqueous solubility and bioavailability (Parhi & Sahoo, 2015) . It has been recently demonstrated that nanotechnology has a great potential for cancer therapy. Cancer nanotechnology is a promising field with extensive applications, and provides a new approach against cancer through target-specific drug therapy (Misra et al., 2010) . Liposome is a small nanoscale vesicle which is produced by suspending natural and synthetic lipids in an aqueous environment. It inhibits the osteoclast-mediated bone resorption and increases Bone Mineral Density (BMD) (Black et al., 2015) . This compound also inhibits the activity of farnesyl diphosphate synthase (FPP synthase). FPP synthase is needed for the production of isoprenoid lipids requisite for prenylation of small GTPases. In addition, the inhibition of FPP synthase activity indirectly blocks protein prenylation resulting in a loss of osteoclast function and apoptosis (Koto et al., 2010 
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NPs characterization
The Size, size distribution and zeta potential of NPs were determined by Zetasizer device (Malvern Instruments LTD). The stability of NPs was also evaluated, regarding the size and size distribution of Zol loaded NPs.
Entrapment efficiency
To estimate drug encapsulation efficiency, 2 ml of nanodrug was centrifuged (21000 rpm, 45 min, 4
• C) and the absorbance was measured at 328 nm by Spectrophotometric method (UV-160IPC, Shimadzu, Japan), and entrapment efficiency was calculated through following equation. % = ×
Cytotoxicity assay
To evaluate the cytotoxicity of Zol loaded NPs, 100 µl of 4T1 cells suspension contained 10000 cells was added to the wells of 96-well plates and incubated (37˚C, 5% CO 2 ). After 24 h, the culture medium was removed and substituted the various concentrations of different drug formulations (Standard Zol and Zol loaded NPs), and then incubated at the mentioned conditions for a further 24 h. Later, culture supernatants were removed, and MTT solution (0.5 mg/ml) was added. After 3 h incubation, the amethyst crystal (formazan) was dissolved in 100 µl Isopropanol. Then, the absorbance was measured at 570 nm, and Inhibitory Concentration of 50 (IC 50 ) was determined using Pharm software.
Statistical analysis
The data showed the mean values from triplicate experiments. They were also statistically analyzed by one-way analysis of variance using IBM Statistics SPSS 19, and significant difference was set at p < 0.05.
Results
NPs characterization
The size, size distribution and Zeta potential of drug loaded NPs were found to be 157 nm, 0.285 and -43 mV, and the values for blank NPs were estimated 147 nm, 0.18 and -50 mV, respectively.
Entrapment efficiency
Entrapment efficiency was calculated to be 9% using spectrophotometric method.
Cytotoxicity assay
The cytotoxicity of Zol loaded NPs relative to standard drug was determined (Figure 1 ). 
Conclusion
The reverse phase evaporation technique was confirmed as an appropriate method. In the present study, the size, size distribution, Zeta potential, encapsulation efficiency and the cytotoxicity of Zol loaded NPs were evaluated. The results showed that the new formulation has a significant cytotoxicity against cancerous cells. This study recommends evaluating the formulation in vivo environment. 
